Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅲ): evaluation of kidney function in patients undergoing anticancer drug therapy (Part 2)

Wang Yina, Zuo Li, Yan Yu

PDF(379 KB)
PDF(379 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (7) : 385-389. DOI: 10.3760/cma.j.cn114015-20240507-00308

Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅲ): evaluation of kidney function in patients undergoing anticancer drug therapy (Part 2)

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(7): 385-389 https://doi.org/10.3760/cma.j.cn114015-20240507-00308

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(379 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉